Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Net Block

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Net Block History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Block ₹18,620 Cr₹19,004 Cr₹4,540 Cr₹4,245 Cr₹3,583 Cr

What is the latest Net Block ratio of MANKIND PHARMA ?

The latest Net Block ratio of MANKIND PHARMA is ₹18,620 Cr based on Mar2026 Consolidated results.
Year Net Block
Mar2026₹18,620 Cr
Mar2025₹19,004 Cr
Mar2024₹4,540 Cr
Mar2023₹4,245 Cr
Mar2022₹3,583 Cr

How is Net Block of MANKIND PHARMA Trending?

Years Net Block % Change
Mar2026 ₹18,620 Cr
-2.02
Mar2025 ₹19,004 Cr
318.61
Mar2024 ₹4,540 Cr
6.94
Mar2023 ₹4,245 Cr
18.49
Mar2022 ₹3,583 Cr -

Compare Net Block of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹97,757.1 Cr -1% -7.2% -4.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹459,952.0 Cr 1% -2.9% 17.4% Stock Analytics
DIVIS LABORATORIES ₹230,427.0 Cr 1.8% 17% 39.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹187,141.0 Cr -1.9% -1.9% 33.2% Stock Analytics
CIPLA ₹114,715.0 Cr 0.3% 0.7% -7.4% Stock Analytics
DR REDDYS LABORATORIES ₹99,409.9 Cr 1.7% 3.5% -4.1% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-1%

-7.2%

-4.7%

SENSEX

0.5%

2.1%

-4.5%


You may also like the below Video Courses